Huons Co., Ltd. (KOSDAQ:243070)

South Korea flag South Korea · Delayed Price · Currency is KRW
26,700
-100 (-0.37%)
Apr 28, 2026, 3:30 PM KST
6.80%
Market Cap 311.10B
Revenue (ttm) 620.77B
Net Income (ttm) 42.66B
Shares Out 11.65M
EPS (ttm) 3,600.00
PE Ratio 7.42
Forward PE n/a
Dividend 920.00 (3.43%)
Ex-Dividend Date Apr 2, 2026
Volume 23,868
Average Volume 20,840
Open 27,250
Previous Close 26,800
Day's Range 26,500 - 27,250
52-Week Range 24,550 - 32,200
Beta 0.15
RSI 53.07
Earnings Date May 15, 2026

About Huons

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, anti-coagulant, antiviral, central nervous system, antibiotic, well-being, urogenital system, and other chemotherapeutic products; and injection products, such as anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic... [Read more]

Sector Healthcare
Founded 1965
Employees 912
Stock Exchange KOSDAQ
Ticker Symbol 243070
Full Company Profile

Financial Performance

In 2025, Huons's revenue was 620.77 billion, an increase of 5.17% compared to the previous year's 590.23 billion. Earnings were 42.66 billion, an increase of 44.84%.

Financial Statements

News

There is no news available yet.